Literature DB >> 2118244

Listeria monocytogenes endophthalmitis in a renal-transplant patient receiving ciclosporin.

M Algan1, B Jonon, J L George, C Lion, M Kessler, J C Burdin.   

Abstract

Endophthalmitis due to Listeria monocytogenes developed suddenly in a 52-year-old man receiving immunosuppressive therapy for a renal transplantation carried out 2 months previously. The treatment combined low doses of ciclosporin and prednisone. The initial clinical picture was of acute hypertensive uveitis with hypopyon. Despite prompt paracentesis and appropriate antibiotic therapy, the long-term course was unfavorable, and enucleation became necessary. The occurrence of listeriosis is classic in renal-transplant recipients, but no ocular form has been reported hitherto.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118244     DOI: 10.1159/000310120

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  5 in total

1.  Endophthalmitis caused by Listeria monocytogenes.

Authors:  C Betriu; S Fuentemilla; R Méndez; J J Picazo; J García-Sánchez
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  Ocular complications associated with cardiac transplantation.

Authors:  F J Wapner; M L Leib; R Drusin; E Rose; B D Srinivasan
Journal:  Trans Am Ophthalmol Soc       Date:  1992

3.  Listeria monocytogenes and ocular abscess: an atypical but yet potential association.

Authors:  Coline Legendre; Hélène Hannetel; Anne-Gaëlle Ranc; Widad Bezza; Laurence Pages; François Vandenesch; Anne Tristan; Anne Doleans-Jordheim
Journal:  Int Ophthalmol       Date:  2017-10-30       Impact factor: 2.031

Review 4.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 5.  Listeria monocytogenes endophthalmitis - case report and review of risk factors and treatment outcomes.

Authors:  Anna Bajor; Anke Luhr; Dorothee Brockmann; Sebastian Suerbaum; Carsten Framme; Ludwig Sedlacek
Journal:  BMC Infect Dis       Date:  2016-07-16       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.